ResearchBy Mayo Clinic Staff
Doctors trained in treating children who have brain and nervous system conditions (pediatric neurologists) and others study potential diagnostic tests, improved treatments and outcomes for adrenoleukodystrophy (ALD). Learn more about research in neurology, pediatric neurology, and blood and marrow transplant.
Doctors study potential treatments, including:
- Medications to lower very long-chain fatty acids levels in your blood
- Lorenzo's oil, a mixture of chemicals, which may help reduce or delay symptoms of ALD by inhibiting the enzyme that causes the lengthening of saturated fatty acids
- Gene therapy to slow progress of the condition
Researchers in the Biochemical Genetics Laboratory at Mayo Clinic in Rochester, Minnesota, study new tests for adrenoleukodystrophy. The Biochemical Genetics Laboratory is one of the few facilities in the United States that performs blood tests to confirm the diagnosis of adrenoleukodystrophy and other metabolic disorders.
See a list of publications by Mayo doctors on adrenoleukodystrophy and adrenomyeloneuropathy on PubMed, a service of the National Library of Medicine.
Dec. 12, 2014
- NINDS Adrenoleukodystrophy information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/adrenoleukodystrophy/adrenoleukodystrophy.htm. Accessed Oct. 11, 2014.
- X-linked adrenoleukodystrophy. Genetics Home Reference. http://ghr.nlm.nih.gov/condition/x-linked-adrenoleukodystrophy. Accessed Oct. 11, 2014.
- Percy AK, et al. Adrenoleukodystrophy. http://www.uptodate.com/home. Accessed Oct. 11, 2014.
- Pagon RA, et al. GeneReviews. Seattle, Wash.: University of Washington, Seattle; 2012. http://www.ncbi.nlm.nih.gov/books/NBK1315/. Accessed Oct. 11, 2014.